Creative Planning
CADX

Creative Planning’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Creative Planning’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,200
Closed -$20K – 3912
2013
Q4 		$20K Buy
+2,200
New +$15.9K ﹤0.01% 2202

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Creative Planning's CADX Position: Q1 2014 in Review

Creative Planning sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 2,200 shares — an estimated $20K sold.

Creative Planning first reported a position in CADX in Q4 2013 and held it in 1 quarter. The position peaked at $20K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Creative Planning reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Creative Planning sold 2,200 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $20K.
  • Creative Planning first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q4 2013 and held it in 1 quarter.
  • Creative Planning's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $20K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Creative Planning's 13F filing for Q1 2014, filed 11 Apr 2014.